Studying rare diseases in real-world evidence often comes with challenges, such as lack of disease-specific diagnosis codes and complex definition of relevant endpoints. Over the years, Quantify has faced these challenges on […]

Denmark, through the Danish Medicines Council, will join FINOSE! We at Quantify foresee that this can potentially be a great preparation for both HTA bodies and pharmaceutical manufacturers for the upcoming EU HTA regulation. The addition of Denmark to FINOSE […]

The Quantify team has had a fantastic first day at #isporannual! Today’s schedule was full with many meetings and interesting program sessions.

One thing is clear – Nordic RWD has great […]

Will you be attending #ISPOR in #Boston next week? Quantify’s Kirk Geale, Emilie Toresson Grip & Puneet Kaushik will be on site and ready to connect at #ISPORAnnual! Keep a lookout for booth […]

The NPF has recently published a new strategy aiming to strengthen the collaboration between the Nordic countries. New, innovative and advanced therapies can offer hope and cure for patients, however it […]

Are you looking for a partner to provide support in Nordic HTA submissions? QUANTIFY is a true pan-Nordic vendor with hands-on expertise in all Nordic countries combined with experience developing Global HEOR material, in addition to local offices and in-house […]

Quantify Research will attend this year’s annual SHEA-conference (Swedish Health Economic Association) in Stockholm on Tuesday and Wednesday (April 25th-26th). Our Nordic HTA experts Lena Jacobs, Hannah Norman and Konstantin Macheridis will participate in this […]

We had a great time at the Nordic Rare Disease Summit 2023 last week, where important topics such as early diagnosis, patient empowerment, access to innovative treatments and EU legislation were discussed. […]